Stockholders' Equity Note Disclosure [Text Block] | NOTE 6 - SHAREHOLDERS’ EQUITY: Incentive Compensation Plan: In 2012, the Company’s Board of Directors and shareholders approved the Company’s 2012 Incentive Compensation Plan (the “2012 Plan”), which provides for the grant of restricted stock awards, non-qualified stock options and incentive stock options in compliance with the Internal Revenue Code of 1986, as amended, to employees, officers, directors, consultants and advisors of the Company who are expected to contribute to the Company’s future growth and success. When originally approved, the 2012 Plan provided for the grant of awards relating to 2,000,000 shares of common stock, plus those shares still available under the Company’s prior incentive compensation plan. In June 2014, the Company’s shareholders approved the Amended and Restated 2012 Incentive Compensation Plan allowing for an additional 1,658,045 shares of the Company’s common stock to be available for future grants under the 2012 Plan. As of December 31, 2015, there were 2,238,500 shares available for issuance under the 2012 Plan, including those shares available under the Company’s prior incentive compensation plan as of such date. All service-based options granted have ten year terms and, from the date of grant, vest annually and become fully exercisable after a maximum of five years. Performance-based options granted have ten year terms and vest and become fully exercisable when determinable performance targets are achieved. Performance targets are agreed to, and approved by, the Company’s board of directors. Under the Company’s 2012 Plan, options may be granted to purchase shares of the Company’s common stock exercisable at prices generally equal to or above the fair market value on the date of the grant. The following summarizes the components of stock-based compensation expense by equity instrument for the years ended December 31: 2015 2014 Service-Based Restricted Common Stock $ 210,600 $ 180,133 Performance-Based Stock Options 85,205 146,838 Performance-Based Restricted Common Stock 16,971 29,954 Total Share-Based Compensation Expense $ 312,776 $ 356,925 Stock-based compensation for the years ended 2015 and 2014 is included in general and administrative expenses in the accompanying consolidated statement of operations. The performance-based and service-based stock options outstanding and exercisable as of December 31, 2015 are summarized as follows: Weighted average Options Options Weighted average exercise price Outstanding Exercisable remaining life Performance-based $ 1.32 1,965,000 1,090,000 5.4 years Service-based $ 2.23 523,000 378,000 2.7 years 2,488,000 1,468,000 Restricted common stock awards: In June 2015, the Company granted 100,000 shares of restricted common stock to certain directors of the Company under the 2012 Plan. The fair market value of shares were granted at a price of $2.22 per share and will fully vest on the date of the Company’s next annual shareholders meeting to be held in June 2016, or a vesting period of approximately one year, provided that the director’s service continues through the vesting date. The total compensation expense to be recognized over the vesting period is $222,000. The following tables summarize the restricted common stock awards granted to certain directors, officers and employees of the Company during the years ended December 31, 2015 and 2014 under the 2012 Plan: Year ended December 31, 2015 Individuals Number Fair Market Vesting Date Board of Directors 100,000 $ 2.22 Next Annual Meeting (June 2016) Year ended December 31, 2014 Individuals Number Fair Market Vesting Date Board of Directors 80,000 $ 2.49 Annual Meeting (June 2015) A summary of the status of the Company’s non-vested restricted common stock, as granted under the Company’s approved stock compensation plan, as of December 31, 2015 and 2014, and changes during the years ended December 31, 2015 and 2014 are presented below: Weighted Average Grant Date Non-vested Shares Number of Shares Fair Value Non-vested at January 1, 2014 220,000 $ 1.63 Granted 80,000 $ 2.49 Vested (113,334 ) $ 1.51 Forfeited (6,666 ) $ 1.51 Non-vested at December 31, 2014 180,000 $ 2.09 Granted 100,000 $ 2.22 Vested (80,000 ) $ 2.49 Forfeited (13,000 ) $ 1.77 Non-vested at December 31, 2015 187,000 $ 2.01 Under the terms of the performance-based restricted common stock award agreements (pertaining to the 100,000 shares of restricted stock awards granted in 2013), the awards will fully vest and become exercisable on the date on which the Company’s Board of Directors shall have determined that specific financial milestones have been met, provided the employee remains in the employ of the Company at such time; provided, however, upon a Change in Control (as defined in the award agreements and the 2012 Plan), the restricted stock shall automatically vest as permitted by the 2012 Plan. For the performance-based restricted stock awarded in 2013, the Company’s Board of Directors adopted specific revenue and earnings performance targets as vesting conditions. During the first quarter of 2015, management determined the performance conditions related to these restricted stock awards are probable to be achieved by the year ending 2020. As a result, the Company adjusted the amortization of the fair market value of these awards over the revised implicit service period from December 2017 to December 2020. The impact of this adjustment for the year ended December 31, 2015 was to reduce stock compensation expense attributable to performance-based restricted common stock awards by $5,989. If management determines in future periods the achievement of performance conditions are probable to occur sooner than expected, the Company will accelerate the expensing of any unamortized balance as of that determination date. As of December 31, 2015, the unearned compensation related to Company granted restricted common stock is $218,064 of which $111,000 (pertaining to 100,000 service-based restricted common stock awards) will be amortized on a straight-line basis through the date of the Company’s next annual meeting to be held in June 2016, the vesting date. The remaining balance of $107,064 (pertaining to 87,000 performance-based restricted common stock awards issued in 2013) will be amortized on a straight-line basis through December 31, 2020, the revised implicit service period. Performance-based stock option awards: A summary of performance-based stock option activity, and related information for the years ended December 31 2015 and 2014 follows: Weighted Average Options Exercise Price Outstanding, January 1, 2014 2,250,000 $ 1.28 Granted — — Vested — — Exercised (180,000 ) $ 0.78 Forfeited — — Expired — — Outstanding, December 31, 2014 2,070,000 $ 1.33 Granted 50,000 $ 1.83 Vested — — Exercised (30,000 ) $ 0.78 Forfeited (125,000 ) $ 1.77 Expired — — Outstanding, December 31, 2015 1,965,000 $ 1.32 Options exercisable: December 31, 2014 1,120,000 $ 0.95 December 31, 2015 1,090,000 $ 0.96 The aggregate intrinsic value of performance-based stock options outstanding (regardless of whether or not such options are exercisable) as of December 31, 2015 and 2014 was $846,350 and $2,690,050, respectively. The aggregate intrinsic value of performance-based stock options exercised in 2015 and 2014 was $42,300 and $320,850, respectively. On September 8, 2015, the Company granted performance-based stock options to a non-executive officer employee to acquire 50,000 shares of common stock at an exercise price of $1.83 per share, which represents the closing price of the Company’s common stock as reported on the NYSE MKT on September 8, 2015, the date of grant. The per share fair-value of these performance-based options was $1.03. The per share fair-value was estimated on the date of grant using the Black-Scholes option pricing method and included the following range of assumptions; dividend yield 0%, risk-free interest rate of 1.53% and expected option life of 4 years. Volatility assumption was 75.46% and the forfeiture rate was assumed to be 0%. Under the terms of the performance-based stock option agreements, the awards will fully vest and become exercisable on the date on which the Company’s Board of Directors shall have determined that specific financial performance milestones have been met, provided the employee remains in the employ of the Company at such time; provided, however, upon a Change in Control (as defined in the stock option agreements and the 2012 Plan), the stock options shall automatically vest as permitted by the 2012 Plan. During the first quarter of 2015, management determined the performance conditions related to stock option awards (pertaining to stock awards granted in 2013 and subsequent grants made) are probable to be achieved by the year ending 2020. As a result, the Company adjusted the amortization of the fair market value of these awards over the revised implicit service period from December 2017 to December 2020. The impact of this adjustment for the year ended December 31, 2015 was to reduce stock compensation expense attributable to performance-based stock option awards by $29,713. If management determines in future periods the achievement of performance conditions are probable to occur sooner than expected, the Company will accelerate the expensing of any unamortized balance as of that determination date. As of December 31, 2015, the unearned compensation related to the 950,000 performance-based stock options granted in August 2013 (with a a weighted average per share exercise price of $1.77) and the 50,000 performance-based stock options granted in September 2015 (with a weighted average per share exercise price of $1.83) is $523,926 and $49,074, respectively, which will be amortized on a straight-line basis through December 31, 2020, the revised implicit service period. The Company’s performance-based stock options granted prior to 2013 (consisting of 1,090,000 options) are fully amortized. For the years ended December 31, 2015 and 2014, the Company recorded compensation expense related to performance-based options in the amount of $85,205 and $146,838, respectively. Service-based stock option awards: A summary of service-based stock option activity, and related information for the years ended December 31, follows: Weighted Average Options Exercise Price Outstanding, January 1, 2014 787,000 $ 2.65 Granted — — Vested — — Exercised (25,000 ) $ 2.60 Forfeited — — Expired (240,000 ) $ 2.96 Outstanding, December 31, 2014 522,000 $ 2.51 Granted 145,000 $ 1.30 Vested — — Exercised — — Forfeited (120,000 ) $ 2.28 Expired (24,000 ) $ 2.55 Outstanding, December 31, 2015 523,000 $ 2.23 Options exercisable: December 31, 2014 522,000 $ 2.51 December 31, 2015 378,000 $ 2.58 The aggregate intrinsic value of service-based stock options (regardless of whether or not such options are exercisable) as of December 31, 2015 and 2014 was $0 and $102,640, respectively. The aggregate intrinsic value of service-based stock options exercised in 2015 and 2014 was $0 and $1,250, respectively. On November 19, 2015, the Company granted service-based stock options to acquire 145,000 shares of common stock at an exercise price of $1.30 per share to the members of the Company’s Strategic and Planning Committee, which represents the closing price of the Company’s common stock as reported on the NYSE MKT on November 19, 2015, the date of grant. The per share fair-value of these service-based options was $0.75. The per share fair-value was estimated on the date of grant using the Black-Scholes option pricing method and included the following range of assumptions; dividend yield 0%, risk-free interest rate of 1.68% and expected option life of 4 years. Volatility assumption was 78.22% and the forfeiture rate was assumed to be 0%. Under the terms of the service-based stock option agreements relating to the November 19, 2015 stock option grants, the awards shall vest in twelve equal quarterly installments over a period of three years and shall be fully vested on November 19, 2018. As of December 31, 2015, the unearned compensation related to the 145,000 service-based stock options granted in November 2015 (with a weighted average per share exercise price of $1.30) is $109,386, which will be amortized on a straight-line basis over the service period through November 2018. At December 31, 2015, the Company’s service-based stock options granted prior to November 2015 were fully amortized. |